Skip to content

Effects of esmolamine and total iliac fascia space block on perioperative neurological cognitive impairment and postoperative rehabilitation in elderly patients with hip fracture

Effects of esmolamine and total iliac fascia space block on perioperative neurological cognitive impairment and postoperative rehabilitation in elderly patients with hip fracture

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057390
Enrollment
Unknown
Registered
2022-03-10
Start date
2022-04-01
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fracture

Interventions

esmolamine group:esmolamine
continuous nerve block group:continuous nerve block

Sponsors

Department of Anesthesiology, affiliated Hospital of Yangzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing hip fracture surgery at selected time; 2. Age 65 and above, regardless of gender; 3. ASA Class I-III; 4.BMI 18~30 kg/m2 5. No mental and nervous system diseases; 6. No pathological fracture, such as bone tumor, bone tuberculosis, osteomyelitis, etc; 7. No puncture site infection; 8. Plan to stay in hospital = 48 hours after surgery; 9. The patient requires to use the self controlled analgesia device after operation; 10. Clearly understand and voluntarily participate in the study, and sign the informed consent form by himself.

Exclusion criteria

Exclusion criteria: 1. Patients with severe heart, liver and kidney dysfunction before operation; 2. Those who have taken analgesic and sedative drugs and alcoholism for a long time; 3. The patient was judged as having difficulty in managing respiratory tract (the modified Markovian score was Grade IV); 4. Previously suffered from severe cerebrovascular disease, Alzheimer's disease, epilepsy, Parkinson's disease and other neuropsychiatric diseases; 5. Previous history of intracranial surgery or brain injury; 6. Those who have serious vision, hearing, language disorders or are unable to communicate for other reasons; 7. Those who are allergic to or contraindicated to ropivacaine and non steroidal anti-inflammatory drugs (NSAID); 8. Emergency surgery or trauma patients.

Design outcomes

Primary

MeasureTime frame
Incidence of perioperative neurocognitive impairment;Postoperative quality of recovery;

Secondary

MeasureTime frame
Hospitalization time;Postoperative complication;

Countries

China

Contacts

Public ContactSun Jianhong

Affiliated Hospital of Yangzhou University

jianhongsun@163.com+86 13605277966

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026